The Cell Based Assay Market is driven by increasing investments in drug discovery and development, fueled by the rising prevalence of chronic diseases. The demand for personalized medicine further accelerates growth, as researchers seek more accurate and relevant testing methods. Additionally, technological advancements, including automation and high-throughput screening, enhance assay efficiency and precision. The integration of 3D cell culture technologies and organ-on-a-chip models offers innovative solutions, making Cell Based assays crucial for pharmaceutical and biotechnology applications.
, /PRNewswire/ — The global Cell Based Assay Market is expected to grow from approximately USD 22.5 billion in 2024 to around USD 32.0 billion by 2031, achieving a compound annual growth rate (CAGR) of about 5.5%. This growth is fueled by increasing investments in drug discovery, the rising prevalence of chronic diseases, and advancements in technologies that enhance the efficiency of assays.
Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=201801
202 – Pages
126 – Tables
37 – Figures
Scope Of The Report
REPORT ATTRIBUTES |
DETAILS |
STUDY PERIOD |
2020-2031 |
BASE YEAR |
2023 |
… |